GW Pharmaceuticals plc (AIM: GWP) is today pleased to announce the appointment of Investec Bank (UK) Limited as Nominated Adviser and Broker to the Company with immediate effect.
GW Pharmaceuticals plc Today: +44 (0)20 7831 3113
Dr Geoffrey Guy, Executive Chairman
Justin Gover, Managing Director
Investec Tel: +44 (0)20 7597 5000
Financial Dynamics Tel: +44 (0)20 7831 3113
Notes to Editors
About GW Pharmaceuticals
GW was founded in 1998 and listed on the AiM, a market of the London Stock Exchange in June 2001. Operating under license from the UK Home Office, the company is developing cannabis-derived pharmaceutical products for patients with multiple sclerosis, neuropathic pain, cancer pain, spinal cord injury, rheumatoid arthritis, and other severe medical conditions.
GW has assembled a team of over 100 scientists with extensive experience in developing both plant-based prescription pharmaceutical products and medicines containing controlled substances. GW is dedicated to developing treatment options that alleviate pain symptoms in patients who suffer from serious ailments.
For further information, please visit the Company’s website: www.gwpharm.com